NCT01209585

A Study to Evaluate BioMarkers in Blood Samples in Subjects With Rheumatoid Arthritis

Study to Evaluate Biomarkers in Blood and Synovial Fluid in Subjects With Rheumatoid Arthritis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 23 (actual)
• Sponsor: MedImmune LLC · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to study the evaluation of blood samples and blood types to identify functional protein in the joints.

Detailed description

Assessment of type I IFN signature in the peripheral blood and activation of type I IFN signaling pathway in synovial fluid (indicating expression of the functional IFN protein in the joints).

Conditions

• Arthritis

Interventions

Type	Name	Description
OTHER	Blood samples	Subjects will have visits on Days 1, 30 and 120.
OTHER	Synovial fluid aspiration	Subjects will have visits on Days 1, 30, and 120.
OTHER	Synovial tissue sample	Subjects will have visits on Days 1, 30, and 120.

Timeline

• Start date: 2011-03-01
• Primary completion: 2012-11-01
• Completion: 2013-03-01
• First posted: 2010-09-27
• Last updated: 2013-07-25

Locations

3 sites across 1 country: United States